Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals
Arab Journal of Gastroenterology (2022) - Comment
pubmed: 35690556  doi: 10.1016/j.ajg.2022.04.005  issn: 1687-1979  issn: 2090-2387 

Mohammed A. Medhat, Mohamed El-Kassas, Haidi Karam-Allah, Ahmed Al Shafie, Sherief Abd-Elsalam, Ehab Moustafa, Sahar M. Hassany, Marwa Salama, Mohamed S. Abd Elghafar, Hamdy Sayed, Mohamed Badr, Dalia T. Kamal, Ahmed Shamseldeen, Ashima'a Ossimi, Inas Moaz, Hossam El-deen Esmael, Azza M. Ezz Eldin, Sameera Ezzat, Hossam Abdelghaffar, Khaled Abdelghaffar